The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Dietary fat intake, pesticide use, and Parkinson's disease
Open accessAbstract
Background Dietary fat intake may modify Parkinson's disease (PD) risk directly or by altering the response to environmental neurotoxicants including pesticides.Methods We conducted a case-control study of PD nested in the Agricultural Health Study (AHS), a cohort of pesticide applicators and spouses. We evaluated diet and pesticide use before diagnosis in 89 PD cases, confirmed by movement disorder specialists, or a corresponding date in 336 frequency-matched controls. Associations were evaluated using multivariate logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs).Results In the AHS, PD was inversely associated with N-3 polyunsaturated fatty acids (PUFAs) (OR 0.4, 95% CI 0.2-0.8 for highest vs. lowest tertile) and the N-3 precursor α-linolenic acid (0.4, 0.2-0.8). In a meta-analysis of nine studies, including the present one, PD was inversely associated with α-linolenic acid (0.81, 0.68-0.96). In the AHS, associations of PD with the pesticides paraquat and rotenone were modified by fat intake. The OR for paraquat was 4.2 (1.5-12) in individuals with PUFA intake below the median but 1.2 (0.4-3.4) in those with higher intake (p-interaction = 0.10). The OR for rotenone was 5.8 (2.3-15) in those with saturated fat intake above the median but 1.5 (0.5-4.2) in those with lower intake (p-interaction = 0.02).Conclusions PUFA intake was consistently associated with lower PD risk, and dietary fats modified the association of PD risk with pesticide exposure. If confirmed, these findings suggest that a diet high in PUFAs and low in saturated fats might reduce risk of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent study demonstrated that dietary fat intake may modify the risk of developing PD directly or by altering the response to environmental neurotoxins; high levels of polyunsaturated fatty acids (PUFAs), like DHA decreased the association of PD with pesticides (Kamel et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Kamel et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adjustment for total energy intake in epidemiologic studies
Willett, W. C., Howe, G., & Kushi, L. H. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.4.1220s · Cited by 3,805
National Center for Health Statistics (NCHS)
Feinleib, M. (2005) · Encyclopedia of Biostatistics · doi:10.1002/0470011815.b2a16042 · Cited by 3,134
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Rotenone, Paraquat, and Parkinson’s Disease
Tanner, C. M., Kamel, F., Ross, G. W., Hoppin, J. A., Goldman, S. M., Korell, M., Marras, C., Bhudhikanok, G. S., Kasten, M., Chade, A. R., et al. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002839 · Cited by 1,565
Self-citationOmega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action
Poudyal, H., Panchal, S. K., Diwan, V., & Brown, L. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.003 · Cited by 391
Fabelo, N., Martín, M. V., Santpere, G., Marín, R., Torrent, L., Ferrer, I., & Díaz, M. L. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00119 · Cited by 379
Oxidative and Inflammatory Pathways in Parkinson’s Disease
Miller, R. L., James-Kracke, M., Sun, G. Y., & Sun, A. Y. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9656-2 · Cited by 306
Dietary lipids and antioxidants in Parkinson's disease: A population‐based, case‐control study
Logroscino, G., Marder, K. S., COTE, L. J., Tang, M., Shea, S., & Mayeux, R. P. (1996) · Annals of Neurology · doi:10.1002/ana.410390113 · Cited by 302
Weight loss in Parkinson's disease
Chen, H., Zhang, S. M., Hernán, M. Á., Willett, W. C., & Ascherio, A. (2003) · Annals of Neurology · doi:10.1002/ana.10577 · Cited by 301
Self-citationDietary fatty acids and the risk of Parkinson disease
de Lau, L. M. L., Bornebroek, M., Witteman, J. C. M., Albert Hofman, D., Koudstaal, P. J., & Breteler, M. M. B. (2005) · Neurology · doi:10.1212/01.wnl.0000166038.67153.9f · Cited by 260
Cited by
Sorted by citations
Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology
Simon, D. K., Tanner, C. M., & Brundin, P. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.08.002 · Cited by 1,114
Self-citationPesticides: an update of human exposure and toxicity
Mostafalou, S., & Abdollahi, M. R. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1849-x · Cited by 787
Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.197 · Cited by 598
Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses
Bellou, V., Belbasis, L., Tzoulaki, I., Εvangelou, Ε., & Ioannidis, J. P. A. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.12.008 · Cited by 443
Review: Sporadic Parkinson's disease: development and distribution ofα‐synuclein pathology
Tredici, K. D., & Braak, H. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12298 · Cited by 416
Gubert, C., Kong, G., Renoir, T., & Hannan, A. J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104621 · Cited by 387
The Role of Lipids in Parkinson’s Disease
Xicoy, H., Wieringa, B., & Martens, G. J. M. (2019) · Cells · doi:10.3390/cells8010027 · Cited by 264
Membrane Lipids in Presynaptic Function and Disease
Lauwers, E., Goodchild, R. E., & Verstreken, P. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.033 · Cited by 236
Parkinson’s disease from the gut
Liddle, R. A. (2018) · Brain Research · doi:10.1016/j.brainres.2018.01.010 · Cited by 228
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials
Avallone, R., Vitale, G., & Bertolotti, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174256 · Cited by 218
The emerging role of nutrition in Parkinson's disease
Seidl, S. E., Santiago, J. A., Bilyk, H. T., & Potashkin, J. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00036 · Cited by 218
The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies
Perez-Pardo, P., Kliest, T., Dodiya, H. B., Broersen, L. M., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.042 · Cited by 203
“A recent study demonstrated that dietary fat intake may modify the risk of developing PD directly or by altering the response to environmental neurotoxins; high levels of polyunsaturated fatty acids (PUFAs), like DHA decreased the association of PD with pesticides (Kamel et al., 2014).”
BackgroundYou’ve got male: Sex and the microbiota-gut-brain axis across the lifespan
Jaggar, M., Rea, K., Spichak, S., Dinan, T. G., & Cryan, J. F. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100815 · Cited by 200
Gorecki, A. M., Preskey, L., Bakeberg, M. C., Kenna, J. E., Gildenhuys, C., MacDougall, G., Dunlop, S. A., Mastaglia, F. L., Akkari, P. A., Koengten, F., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00839 · Cited by 184
Preventing Parkinson’s Disease: An Environmental Agenda
Miranda, B. R. D., Goldman, S. M., Miller, G. W., Greenamyre, J. T., & Dorsey, E. R. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212922 · Cited by 171
Self-citationDiet in Parkinson’s Disease: Critical Role for the Microbiome
Jackson, A., Forsyth, C. B., Shaikh, M., Voigt, R. M., Engen, P. A., Ramirez, V., & Keshavarzian, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01245 · Cited by 145
Healy-Stoffel, M., & Levant, B. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666180412153612 · Cited by 133
Neurotoxicity of pesticides – A link to neurodegeneration
Vellingiri, B., Chandrasekhar, M., Sabari, S. S., Gopalakrishnan, A. V., Narayanasamy, A., Venkatesan, D., Iyer, M., Kesari, K. K., & Dey, A. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113972 · Cited by 123
Parkinson’s disease and pesticides: A meta-analysis of disease connection and genetic alterations
Ahmed, H., Abushouk, A. I., Gabr, M., Negida, A., & Abdel‐Daim, M. M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.100 · Cited by 118
Gut-brain and brain-gut axis in Parkinson’s disease models: effects of a uridine and fish oil diet
Perez-Pardo, P., Dodiya, H. B., Broersen, L. M., Douna, H., van Wijk, N., Lopes da Silva, S., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1294555 · Cited by 111
Nutritional Risk Factors, Microbiota and Parkinson’s Disease: What Is the Current Evidence?
Boulos, C., Yaghi, N., El Hayeck, R., Heraoui, G. N., & Fakhoury-Sayegh, N. (2019) · Nutrients · doi:10.3390/nu11081896 · Cited by 109
The complex relationship between obesity and neurodegenerative diseases: an updated review
Neto, A., Fernandes, A. M. A., & Barateiro, A. P. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1294420 · Cited by 120
Dietary Factors in the Etiology of Parkinson’s Disease
Ağım, Z. S., & Cannon, J. R. (2015) · BioMed Research International · doi:10.1155/2015/672838 · Cited by 115
Tanner, C. M., Goldman, S. M., Ross, G. W., & Grate, S. J. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.014 · Cited by 119
Self-citationTLR2 and TLR4 in Parkinson’s disease pathogenesis: The environment takes a toll on the gut
Gorecki, A. M., Anyaegbu, C. C., & Anderton, R. S. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00271-0 · Cited by 103
Paraquat and Parkinson’s disease: a systematic review and meta-analysis of observational studies
Vaccari, C., Dib, R. E., Gomaa, H. A., Lopes, L. C., & de Camargo, J. L. V. (2019) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2019.1659197 · Cited by 105
Smeyne, R. J., Breckenridge, C. B., Beck, M. J., Jiao, Y., Butt, M. T., Wolf, J. C., Zadory, D., Minnema, D. J., Sturgess, N. C., Travis, K. Z., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164094 · Cited by 98
Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson Disease
Schrag, A. E., Bohlken, J., Dammertz, L., Teipel, S. J., Hermann, W., Akmatov, M. K., Bätzing, J., & Holstiege, J. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.3902 · Cited by 96
Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders
Hashimoto, K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00036 · Cited by 95
Hernando, S., Requejo, C., Herrán, E., Ruíz-Ortega, J. Á., Morera‐Herreras, T., Lafuente, J. V., Ugedo, L., Gaínza, E., Pedraz, J. L., Igartúa, M., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.001 · Cited by 92
Pesticide use and incident Parkinson's disease in a cohort of farmers and their spouses
Shrestha, S., Parks, C. G., Umbach, D. M., Richards-Barber, M., Hofmann, J. N., Chen, H., Blair, A. E., Freeman, L. E. B., & Sandler, D. P. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110186 · Cited by 90
Self-citationBiological functions of selenium and its potential influence on Parkinson's disease
Ellwanger, J. H., Franke, S. I. R., Bordin, D. L., Prá, D., & Henriques, J. A. P. (2016) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201620150595 · Cited by 88
Morais, L. H., Hara, D. B., Bicca, M. A., Poli, A., & Takahashi, R. N. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000389 · Cited by 58
Caggiu, E., Paulus, K. S., Arru, G., Piredda, R., Sechi, G., & Sechi, L. A. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.01.007 · Cited by 69
Alteration in the Cerebrospinal Fluid Lipidome in Parkinson’s Disease: A Post-Mortem Pilot Study
Fernández‐Irigoyen, J., Cartas‐Cejudo, P., Iruarrizaga‐Lejarreta, M., & Santamaría, E. (2021) · Biomedicines · doi:10.3390/biomedicines9050491 · Cited by 64
Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota
Yemula, N., Dietrich, C. M., Dostal, V., & Hornberger, M. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212707 · Cited by 71
Hachem, M., & Nacir, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073969 · Cited by 61
Schwamborn, J. C. (2018) · Stem Cells and Development · doi:10.1089/scd.2017.0289 · Cited by 62
Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
Alfonsetti, M., Castelli, V., & d’Angelo, M. (2022) · Nutrients · doi:10.3390/nu14020380 · Cited by 61
Kanthasamy, A., Jin, H., Charli, A., Anantharam, V., & Kanthasamy, A. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.01.001 · Cited by 57
NLRP inflammasome as a key role player in the pathogenesis of environmental toxicants
Moloudizargari, M., Moradkhani, F., Asghari, N., Fallah, M., Asghari, M. H., Moghadamnia, A. A., & Abdollahi, M. R. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116585 · Cited by 53
Relationship between high dietary fat intake and Parkinson’s disease risk: a meta-analysis
Sun, Q., Qu, Y., Chen, X., & Xu, M. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.262599 · Cited by 51
McCarty, M. F., & Lerner, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103624 · Cited by 51
Ratner, M. H., Farb, D. H., Ozer, J. S., Feldman, R. G., & Durso, R. (2014) · Interdisciplinary Toxicology · doi:10.2478/intox-2014-0017 · Cited by 49
A nutritional approach to microbiota in Parkinson’s disease
Uyar, G. Ö., & Yıldıran, H. (2019) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.19-002 · Cited by 49
Dietary fat intake and risk for Parkinson's disease
Dong, J., Beard, J. D., Umbach, D. M., Park, Y., Huang, X., Blair, A. E., Kamel, F., & Chen, H. (2014) · Movement Disorders · doi:10.1002/mds.26032 · Cited by 42
Self-citationAlterations in Lipid and Inositol Metabolisms in Two Dopaminergic Disorders
Schulte, E. C., Altmaier, E., Berger, H. S., Do, K. T., Kastenmüller, G., Wahl, S., Adamski, J., Peters, A., Krumsiek, J., Suhre, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147129 · Cited by 41
Wang, C., Wang, D., Zhang, T., Yanagita, T., Xue, C., Chang, Y., & Wang, Y. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.09.027 · Cited by 42
Kulcsarova, K., Bang, C., Berg, D., & Schaeffer, E. (2023) · Journal of Parkinson’s Disease · doi:10.3233/jpd-230206 · Cited by 40
Pantzaris, M., Loukaides, G. N., Paraskevis, D. N., Kostaki, E. G., & Patrikios, I. S. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2021.106954 · Cited by 40
Schommer, J., Marwarha, G., Nagamoto‐Combs, K., & Ghribi, O. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00552 · Cited by 38
Macronutrients intake and risk of P arkinson's disease: A meta‐analysis
Wang, A., Lin, Y., Wu, Y., & Zhang, D. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12321 · Cited by 38
Impact of DHA intake in a mouse model of synucleinopathy
Coulombe, K., Kerdiles, O., Tremblay, C., Émond, V., Lebel, M., Boulianne, A.-S., Plourde, M., Cicchetti, F., & Calon, F. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.12.002 · Cited by 38
The Role of the Western Diet and Oral Microbiota in Parkinson’s Disease
Zapała, B., Stefura, T., Milewicz, T., Wątor, J., Piwowar, M. W., Wójcik-Pędziwiatr, M., Doręgowska, M., Dudek, A., Jania, Z., & Rudzińska, M. (2022) · Nutrients · doi:10.3390/nu14020355 · Cited by 38
Ristori, S., Bertoni, G., Bientinesi, E., & Monti, D. (2025) · Nutrients · doi:10.3390/nu17111837 · Cited by 43
Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson’s Disease
Xicoy, H., Brouwers, J. F. H. M., Kalnytska, O., Wieringa, B., & Martens, G. J. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01733-3 · Cited by 32
Dietary fat intake and risk of Parkinson disease: results from the Swedish National March Cohort
Hantikainen, E. M., Röös, E., Bellocco, R., D’Antonio, A., Grotta, A., Adami, H., Ye, W., Lagerros, Y. T., & Bonn, S. E. (2022) · European Journal of Epidemiology · doi:10.1007/s10654-022-00863-8 · Cited by 31
Wang, Y., Plastina, P., Vincken, J., Jansen, R., Balvers, M. G. J., ten Klooster, J. P., Gruppen, H., Witkamp, R. F., & Meijerink, J. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00298 · Cited by 31
Pallàs, M., Vázquez, S., Sanfeliu, C., Galdeano, C., & Griñán‐Ferré, C. (2020) · Biomolecules · doi:10.3390/biom10050703 · Cited by 33
Nutrition and Lifestyle Interventions for Managing Parkinson’s Disease: A Narrative Review
Lister, T. (2020) · Journal of Movement Disorders · doi:10.14802/jmd.20006 · Cited by 33
Zhu, X., Huang, S., Kang, W., Chen, P., & Liu, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1123239 · Cited by 27
Dietary patterns affect Parkinson's disease via the microbiota-gut-brain axis
Chu, C., Yu, L., Chen, W., Tian, F., & Zhai, Q. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.07.004 · Cited by 27
Parkinson's disease: the nutrition perspective
Breasail, M. Ó., Smith, M. D., Tenison, E., Henderson, E. J., & Lithander, F. E. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003645 · Cited by 32
Rasheed, M. Z., Khatoon, R., Talat, F., Alam, M. M., Tabassum, H., & Parvez, S. (2023) · ACS Omega · doi:10.1021/acsomega.2c03992 · Cited by 25
Puschmann, A., Brighina, L., Markopoulou, K., Aasly, J. O., Chung, S. J., Frigerio, R., Hadjigeorgiou, G. M., Kõks, S., Krüger, R., Siuda, J. S., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.04.029 · Cited by 25
Paraquat and psychological stressor interactions as pertains to Parkinsonian co-morbidity
Rudyk, C., Litteljohn, D., Syed, S., Dwyer, Z., & Hayley, S. P. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2015.09.001 · Cited by 25
Drobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24
Metabolomics in Parkinson’s Disease and Correlation with Disease State
Ostrakhovitch, E. A., Ono, K., & Yamasaki, T. R. (2025) · Metabolites · doi:10.3390/metabo15030208 · Cited by 24
Jones, B. C., Huang, X., Mailman, R. B., Lu, L., & Williams, R. W. (2014) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21552 · Cited by 21
Andersen, K. B., Johansen, J. L., Hentzer, M., Smith, G. P., & Dietz, G. P. H. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00164 · Cited by 21
Cannabinoids in Health and Disease
Meccariello, R., & Chianese, R. (2016) · InTech eBooks · doi:10.5772/61595 · Cited by 22
Gorecki, A. M., Bakeberg, M. C., Theunissen, F., Kenna, J. E., Hoes, M. E., Pfaff, A. L., Akkari, P. A., Dunlop, S. A., Kõks, S., Mastaglia, F. L., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.603849 · Cited by 21
Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases
Bosch‐Bouju, C., & Layé, S. (2016) · InTech eBooks · doi:10.5772/62498 · Cited by 22
Recent Research on Occupational Animal Exposures and Health Risks: A Narrative Review
Dignard, C., & Leibler, J. H. (2019) · Current Environmental Health Reports · doi:10.1007/s40572-019-00253-5 · Cited by 18
Human gut microbiota and Parkinson's disease
Pant, A., Bisht, K. S., Aggarwal, S., & Maiti, T. K. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.08.004 · Cited by 17
Zailani, H., Satyanarayanan, S. K., Liao, W.-C., Hsu, Y., Huang, S., Gałecki, P., Su, K., & Chang, J. P. (2023) · Nutrients · doi:10.3390/nu15204363 · Cited by 17
Earle‐Richardson, G. B., Scribani, M., Scott, E., May, J. J., & Jenkins, P. (2014) · The Journal of Rural Health · doi:10.1111/jrh.12098 · Cited by 17
Oguro, A., Ishihara, Y., Siswanto, F. M., Yamazaki, T., Ishida, A., Imaishi, H., & Imaoka, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158858 · Cited by 18
Dhanawat, M., Mehta, D. K., Gupta, S., & Das, R. (2020) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524920666200705222842 · Cited by 17
Identification of gut metabolites associated with Parkinson’s disease using bioinformatic analyses
Yan, J., Feng, X., Zhou, X., Zhao, M., Xiao, H., Li, R., & Shen, H. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.927625 · Cited by 15
Huang, W., Xiao, Y., Zhang, L., & Hu, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26557 · Cited by 15
Choi, J., Polcher, A. A., & Joas, A. (2016) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2016.en-955 · Cited by 18
Dietary Inflammatory Index score and prodromal Parkinson's disease incidence: The HELIAD study
Balomenos, V., Bounou, L., Charisis, S., Stamelou, M., Ntanasi, E., Georgiadi, K., Mourtzinos, I., Tzima, K., Anastasiou, C. A., Xiromerisiou, G., et al. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.108994 · Cited by 14
Detopoulou, P., Voulgaridou, G., Saridaki, A., Argyris, E. M., Seva, V., Dedes, V., Giaginis, C., Panoutsopoulos, G. I., & Papadopoulou, S. Κ. (2024) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2024.03.007 · Cited by 13
Parkinson disease is a fatty acidopathy
Fanning, S., & Selkoe, D. J. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01142-2 · Cited by 18
Lipid metabolism in dopaminergic neurons influences light entrainment
Fernandez, R. F., Wilson, E. S., Diaz, V. D., Martínez‐Gardeazabal, J., Foguth, R. M., Cannon, J. R., Jackson, S. N., Hermann, B. P., Eells, J. B., & Ellis, J. M. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15793 · Cited by 13
Fox, M. A., Niemeier, R. T., Hudson, N. L., Siegel, M. R., & Dotson, G. S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18115850 · Cited by 13
Bioactive lipids and their metabolism: New therapeutic opportunities for Parkinson's disease
Shen, W., Jiang, L., Zhao, J., Wang, H., Hu, M., Chen, L., & Chen, Y. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15566 · Cited by 13
Petit, P., Berger, F. R., Bonneterre, V., & Vuillerme, N. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-024-00864-2 · Cited by 11
Kubo, S. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1086340 · Cited by 11
Nutritional aspects in Parkinson’s disease
Gątarek, P., & Kałużna‐Czaplińska, J. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1902261 · Cited by 10
Şimşek, H., & Uçar, A. (2024) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2024.05.012 · Cited by 10
Bertoni, G., Ristori, S., & Monti, D. (2026) · Cells · doi:10.3390/cells15080657 · Cited by 10
Nutrition and Gastrointestinal Health as Modulators of Parkinson’s Disease
Rasmussen, H. E., Piazza, B., Forsyth, C. B., & Keshavarzian, A. (2014) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-06151-1_11 · Cited by 9
Gastrointestinal dysfunction in Parkinson's disease
Timpka, J., & Odin, P. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.07.004 · Cited by 7
Zhang, F., Liu, Y., Zhu, Y., Yu, Q.-Y., Msigwa, S. S., Zeng, Z.-H., Zhang, X., Wu, H.-M., & Zhu, J. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.01.028 · Cited by 7
Sakib, N., Chowdhury, U. N., Islam, M. B., Ahmad, S., & Moni, M. A. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100448 · Cited by 5
NTP Research Report on the Scoping Review of Paraquat Dichloride Exposure and Parkinson’s Disease
Boyd, W. A., Blain, R. B., Skuce, C. R., Thayer, K. A., & Rooney, A. A. (2020) · doi:10.22427/ntp-rr-16 · Cited by 5
Sakib, N., Chowdhury, U. N., Islam, M. B., Quinn, J. M. W., & Moni, M. A. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/482760 · Cited by 5
Diet for the prevention and treatment of Parkinson’s disease
Chen, W., Fan, T., & Xu, R. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1587246 · Cited by 4
Metadata
- Authors
- Kamel, F., Goldman, S. M., Umbach, D. M., Chen, H., Richardson, G., Barber, M. R., Meng, C., Marras, C., Korell, M., Kasten, M., Hoppin, J. A., Comyns, K., Chade, A., Blair, A., Bhudhikanok, G. S., Webster Ross, G., William Langston, J., Sandler, D. P., & Tanner, C. M.
- Affiliations
- National Institutes of Health (US)
- Parkinson's Institute and Clinical Center (US)
- University of Toronto (CA)
- University of Lübeck (DE)
- Favaloro University (AR)
- United States Department of Health and Human Services (US)
- Corresponding author
- Kamel, Freya
- ORCID
- Venue
- Parkinsonism & Related Disorders
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 20
- Issue
- 1
- Pages
- 82-87
- ISSN
- 1353-8020 (ISSN-L)
- PMC
- PMC3936597
- OpenAlex
- W2058530978
- Cited by
- 127
- References
- 35
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 5 · 2023: 11 · 2022: 10 · 2021: 12 · 2020: 11 · 2019: 17 · 2018: 8 · 2017: 5 · 2016: 13 · 2015: 11 · 2014: 10
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Parkinsonism & Related Disorders (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIEHS (R01-ES10803)
- National Institute of Environmental Health Sciences (Z01-ES044007, Z01-ES049030)
- National Cancer Institute grant (Z01-CP010119)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- Parkinson's disease, dietary fat intake
- MeSH terms
- Adult, Aged, Aged, 80 and over, Diet, Dietary Fats, Female, Humans, Male, Middle Aged, Parkinson Disease, Pesticides, Risk Factors, Fatty Acids, Omega-3, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
